Use of ceftaroline in the management of vertebral osteomyelitis case report

Hadeel Zainah, Marwa Hammoud, Jose Antonio Vazquez

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

Original languageEnglish (US)
Pages (from-to)269-271
Number of pages3
JournalInfectious Diseases in Clinical Practice
Volume21
Issue number4
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Osteomyelitis
Bacterial Pneumonia
Skin
Gram-Positive Bacteria
United States Food and Drug Administration
Cephalosporins
Methicillin-Resistant Staphylococcus aureus
Infection
T 91825

Keywords

  • Ceftaroline
  • Osteomyelitis
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Use of ceftaroline in the management of vertebral osteomyelitis case report. / Zainah, Hadeel; Hammoud, Marwa; Vazquez, Jose Antonio.

In: Infectious Diseases in Clinical Practice, Vol. 21, No. 4, 2013, p. 269-271.

Research output: Contribution to journalArticle

@article{1ab1b3688a9f454c9dab5d97d7d01124,
title = "Use of ceftaroline in the management of vertebral osteomyelitis case report",
abstract = "Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.",
keywords = "Ceftaroline, Osteomyelitis, Staphylococcus aureus",
author = "Hadeel Zainah and Marwa Hammoud and Vazquez, {Jose Antonio}",
year = "2013",
doi = "10.1097/IPC.0b013e318276959f",
language = "English (US)",
volume = "21",
pages = "269--271",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Use of ceftaroline in the management of vertebral osteomyelitis case report

AU - Zainah, Hadeel

AU - Hammoud, Marwa

AU - Vazquez, Jose Antonio

PY - 2013

Y1 - 2013

N2 - Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

AB - Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

KW - Ceftaroline

KW - Osteomyelitis

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=85027920692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027920692&partnerID=8YFLogxK

U2 - 10.1097/IPC.0b013e318276959f

DO - 10.1097/IPC.0b013e318276959f

M3 - Article

AN - SCOPUS:85027920692

VL - 21

SP - 269

EP - 271

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 4

ER -